Latest Content

Unraveling Disparities and Genomic Advances Across Breast Cancer Care

March 23rd 2025, 6:00pm

By Ryan Scott

Article

Dr. Regina Hampton shares case studies from her own practice, illustrating how genomic insights have improved patient outcomes in those with breast cancer.

Reducing Bowel Complications Following Radiation in Prostate Cancer

March 23rd 2025, 2:00pm

By Ryan Scott

Article

SpaceOAR Hydrogel reduced the risk of bowel disorders, the need for colonoscopy and rectal resection following radiation therapy in prostate cancer.

First Patients Dosed in WU-CART-007 Trial for Blood Cancer Subtypes

March 22nd 2025, 6:00pm

By Alex Biese

Article

The first patients have been dosed in a trial of CAR T therapy in relapsed/refractory T cell acute lymphoblastic leukemia or T cell lymphoblastic lymphoma.

Padcev With or Without Keytruda Elicits Responses in Urothelial Cancer

March 22nd 2025, 2:00pm

By Alex Biese

Article

In metastatic urothelial carcinoma, Padcev plus Keytruda elicited responses in the first-line setting, with Padcev showing benefit in later lines.

First Patent Dosed With Pocenbrodib in Trial for Metastatic Prostate Cancer

March 21st 2025, 9:00pm

By Spencer Feldman

Article

First patient dosed in phase 1b/2a trial for castration-resistant metastatic prostate cancer, evaluating pocenbrodib alone and with other drug combinations.

Advancing ctDNA for Minimal Residual Disease Detection in Breast Cancer

March 21st 2025, 8:00pm

By Ryan Scott

Article

Dr. Debu Tripathy explains how ctDNA is used to in breast cancer detection and how it can also indicate the presence of MRD.

Emphasizing the Importance of Breast Cancer Education and Screenings

March 21st 2025, 7:00pm

By Patricia Jakel, RN

Video

Registered nurse Patricia Jakel emphasizes the importance of educating patients on evolving breast cancer research and the need for routine screenings.

The Unseen Long-Term Effects After Follicular Lymphoma Treatment

March 21st 2025, 5:00pm

By Karen Cohn

Article

Life after treatment for follicular lymphoma brings long-term physical and emotional challenges, including immune system impacts and lasting social effects.

FDA Grants Fast Track Designation for Azer-Cel in Lymphoma Subset

March 21st 2025, 4:00pm

By Spencer Feldman

Article

FDA grants fast track designation to azer-cel, an allogeneic CAR T-cell therapy, for relapsed or refractory diffuse large B-cell lymphoma.

FDA Approves Gozellix for Advanced PSMA-PET Imaging in Prostate Cancer

March 21st 2025, 2:02pm

By Ryan Scott

Article

The FDA has approved the use of Gozellix, a PSMA-PET imaging agent, to help detect prostate cancer using gallium-68 gozetotide in PSMA-PET scans.

Understanding NCCN Guidelines: Gavreto in First-Line RET Fusion NSCLC

March 21st 2025, 1:00pm

By Spencer Feldman

Article

Gavreto is recommended as a first-line treatment for metastatic RET fusion-positive, metastatic non-small cell lung cancer, with potential severe side effects.

Evolving Treatments and Advances in HER2-Positive Breast Cancer

March 20th 2025, 9:00pm

By Ryan Scott

Article

Dr. Sara M. Tolaney discussed HER2-positive breast cancer, highlighting key trials, evolving treatment strategies, and the potential for improved outcomes.

The Power of Knowledge and Staying Informed in Breast Cancer Care

March 20th 2025, 8:00pm

By Dr. Debu Tripathy

Video

Dr. Debu Tripathy highlights the importance of staying informed on breast cancer advancements and how this empowers patients to make informed decisions.

What Patients With Breast Cancer Need to Know About Itovebi

March 20th 2025, 7:05pm

By Alex Biese

Article

Itovebi, approved for some patients with breast cancer, is the first PI3K inhibitor to display a survival benefit, according to Dr. Kevin Kalinsky.

A Heaven-Sent Sign About My Brother’s Lymphoma

March 20th 2025, 5:00pm

By Laura Yeager

Article

Cancer runs in the family, and after I’d dealt with two breast cancers, my brother came down with lymphoma.